The current study investigates the functional state of erythrocytes and indices of the oxygen-binding capacity of hemoglobin in\nblood samples from healthy donors and from patients with coronary artery disease and myocardial infarction before and after\ntreatment. It has been established that, in cardiovascular diseases, erythrocyte morphology and hemoglobin oxygen-transporting\ndisorders are observed. Standard therapy does not result in the restoration of the structure and properties of erythrocytes. The\nauthors believe that it is necessary for future therapeutic treatment to include preparations other than cardiovascular agents to\nenhance the capacity of hemoglobin to transport oxygen to the tissues.\n1. Introduction\nCurrently, cardiovascular diseases are the most common diseases\nand are one of the leading causes of death and disability\namong able-bodied populations in economically developed\ncountries [1ââ?¬â??3]. By 2020, the World Health Organization\nestimates that there will be nearly 25 million deaths due to\ncardiovascular diseases worldwide.\nMore than half of deaths due to cardiovascular system\ndiseases are caused by coronary artery disease (CAD). One\nin fivemen aged from50 to 59 years suffers fromthis disease,\nand the incidence and mortality rates are increasing every\nyear.Coronary artery disease may causemyocardial infarction,\napoplectic attack, or heart failure. Acute heart failure (AHF)\nremains one of the most actual and important problems of\nmodern cardiology. Acute heart failure is a clinical syndrome\ncharacterised by early onset of disturbed cardiac function\nsymptoms (reduced cardiac output and inadequate blood\nsupply)
Loading....